HMD Clinical
↗Bathgate, United Kingdom
HMD Clinical was a specialized provider of clinical trial control and reporting solutions, with a primary focus on Randomization and Trial Supply Management (RTSM). Their platform offered tools for randomization, cohort management, study management, and patient compliance through electronic subject diaries.
In April 2021, the company was acquired by Medrio, a leading provider of eClinical technology. The acquisition was strategic, aimed at integrating HMD Clinical's RTSM expertise with Medrio's existing electronic data capture (EDC) suite to offer a more comprehensive, unified eClinical platform for pharmaceutical, biotech, and medical device companies.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2002
Ownership:subsidiary
Status:acquired
0
CORPORATE STRUCTURE
Parent Company:Medrio
Acquired By:Medrio (2021-04-01)
Key Partnerships:Medrio (Long-standing partner prior to acquisition)
COMPETITION
Position:Niche Player
Competitors:Medidata, IQVIA, Verily, Cenduit, Signant Health, 4g Clinical
LEADERSHIP
Key Executives:
Ian Davison - Co-Founder
Brent Harlow - Co-Founder
LINKS
Website:hmdclinical.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of HMD Clinical and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with HMD Clinical. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.